RecruitingNCT07028190

Changes in Rimazolen Dosage in Insomnia Patients Undergoing Digestive Endoscopy

Changes in Rimazolen Dosage in Insomnia Patients Undergoing Digestive Endoscopy: a Prospective Cohort Study


Sponsor

Beijing Tiantan Hospital

Enrollment

840 participants

Start Date

Jun 12, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

To compare the dosage requirement of rimazolen during digestive endoscopy between patients with insomnia and those with normal sleep pattern.


Eligibility

Min Age: 18 YearsMax Age: 64 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying No interventions, it is a observational study for people with digestive endoscopy and insomnia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 64 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo interventions, it is a observational study

No interventions, this study is to compare the dosage requirement of ciprofol during digestive endoscopy between insomnia group and normal sleep group.


Locations(1)

Beijing Tiantan Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07028190


Related Trials